Tumor growth and subsequent mouse survival showed that peritumoral injection of T cell depots infused with pmel CD8+ T cells resulted in significant enhancement of tumor control over intravenously (IV) injected T cells and direct peritumoral T cell injection (Fig. 2b, c). This evidence concerns the gene CD8A and neoplasm.